Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: A community-based retrospective longitudinal cohort study

Journal of Gastroenterology

Volumn 48, Issue 3, 2013, Pages 413-422

  Miyake, Teruki ^a   Kumagi, Teru ^a   Hirooka, Masashi ^a   Furukawa, Shinya ^a   Koizumi, Mitsuhito ^a,b   Tokumoto, Yoshio ^a   Ueda, Teruhisa ^a   Yamamoto, Shin ^a   Abe, Masanori ^a   Kitai, Kohichiro ^b   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ehime General Health Care Association   (Japan)

Author keywords

Body mass index; Metabolic disorders; Nonalcoholic fatty liver disease; Predictive factor

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; FEMALE; HUMAN; JAPANESE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; ADOLESCENT; AGED; BLOOD; EARLY DIAGNOSIS; FATTY LIVER; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; EARLY DIAGNOSIS; FATTY LIVER; FEMALE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84884651279     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0650-8     Document Type: Article

References (30)

1. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132: 112-7.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40: 1387-95.
3. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol. 2005;43: 508-14.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;18: 1221-31.
5. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37: 917-23.
6. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Hepatol. 2002;37: 154-60.
7. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143: 722-8.
8. Akbar DH, Kawther AH. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care. 2003;26: 3351-2.
9. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol. 2004;19: 854-8.
10. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci. 2000;45: 1929-34.
11. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53: 1020-3.
12. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13: 1579-84.
13. Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, et al. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care. 2011;34: 727-9.
14. Miyake T, Kumagi T, Hirooka M, Koizumi M, Furukawa S, Ueda T, et al. Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. J Gastroenterol. 2012;47: 696-703.
15. Yu C, Xu C, Xu L, Yu J, Miao M, Li Y. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. J Hepatol. 2011;56: 241-7.
16. Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE. 2010;5:e11578.
17. Chang Y, Ryu S, Sung E, Jang Y. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;53: 686-92.
18. Omagari K, Morikawa S, Nagaoka S, Sadakane Y, Sato M, Hamasaki M, et al. Predictive factors for the development or regression of fatty liver in Japanese adults. J Clin Biochem Nutr. 2009;45: 56-67.
19. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66: 987-92.
20. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38: 954-61.
21. Prati D, Taioli E, Zanella A, Torre ED, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137: 1-9.
22. Lee JK, Shim JH, Lee HC, Lee SH, Kim KM, Lim YS, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology. 2010;51: 1577-83.
23. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983.
24. Nugent C, Younossi ZM. Evaluation and management of obesityrelated nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4: 432-41.
25. Fujikawa K, Ohata K, Honda T, Miyazoe S, Ichikawa T, Ishikawa H, et al. Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction. Intern Med. 2004;43: 289-94.
26. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and investigation strategies. Lancet. 2004;363: 157-63.
27. Shiwaku K, Anuurad E, Enkhmaa B, Nogi A, Kitajima K, Shimono K, et al. Overweight Japanese with body mass indexes of 23.0-24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians. Int J Obes Relat Metab Disord. 2004;28: 152-8.
28. Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res. 2007;125: 345-54.
29. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev. 2002;3: 141-6.
30. Misra A, Wasir JS, Vikram NK. Action and research are needed for evaluation of optimal definitions of anthropometric parameters and metabolic syndrome for Asians. Diabetes Res Clin Pract. 2005;68: 178-9.